JOHNSON & JOHNSON (NYSE: JNJ)

Overview
current price
$187.24
$187.24
change
0.67 | 0.36%
0.67 | 0.36%
Yesterday's Close
186.57
open
186.00
volume
1.43 M
30d. avg volume.
8.29 M
1 day
185.12 - 187.42
52 weeks
140.68 - 194.48
p/e
19.98
beta
0.3751
market cap
449.50 B
dividend yield
2.79%
Industry
-
News and Commentary
Microsoft, Meta Stocks Add $440 Billion In A Day—Nearly Matching Netflix's Entire $503 Billion Marke... Microsoft Corp. (MSFT&...
Drug Prices To Get 'More Expensive' Under Trump's EU Trade Deal As Pharma Faces Billions In Added Co... The pharmaceutical industry could face a significant financial hit due to the new trade deal between the U.S. and the European Union (EU), potentially leading to increased drug p...
3 Pharma Stocks That Aren't Sweating the Coming 200% Drug Tariffs On July 8, US President Donald Trump shook the biopharmaceutical sector by announcing a tariff of up to 200% on pharmaceuticals, which would take effect "very soon." 80% of presc...
Trump Tariffs Forces AstraZeneca To Bring Substantial Pharmaceutical Production To US AstraZeneca plc (AZN&nb...
Apple's Online Store Is Now Live In Saudi Arabia, Flagship Stores Coming By 2026 Apple (AAPL 
Johnson & Johnson Lifts Annual Forecast After Strong Cancer Drugs, Medtech Performance Johnson & Johnson (JNJ&...
Market Update: Stocks Post Modest Gains Ahead of Busy Week of Data, Earnings and Tariffs Stocks posted muted gains on Monday as market participants traded cautiously ahead of a busy week of inflation readings and second-quarter earnings reports. Investors also monito...
Market Update: Dow Falls 280 Points on New 35% Tariff on Canada Stocks fell lower Friday, pulling major averages into the red for the week, as President Donald Trump announced a surprise 35% tariff on imports from Canada and threatened higher...
Apple, Nvidia, GM: CEOs Are Talking About Being American-Made Again Silicon Valley giants and at least one iconic Detroit auto manufacturer are gearing up for a corporate homecoming-or so they say.According to Charles Sc...
Johnson & Johnson Q1 Earnings: Strong Cancer Drug Sales, Boosts Quarterly Dividend, Anticipates Nega... Johnson & Johnson (JNJ&...
StockTwits
StockTwits

Join now and unlock premium features